mSMART is a new resource from the Mayo Clinic similar to physician refernces like National Comprehensive Cancer Network (NCCN) and Up to Date that is specifically for Multiple Myeloma treatment for physicians to find up to date treatments. These new treatments are revised twice a year.
Evidenced based treatment is always the best treatment in Multiple Myeloma
mSmart separates patients into groups based on their likelihood to repond to treatment. Based on R-ISS guidelines and high risk features. This process uses risk stratification strategys for treatment selection.
Other high risk features the Physicians at Mayo Clinic consider are: